Clinical trial update: International Breast Cancer Study Group

Karen N. Price, Aron Goldhirsch

Research output: Contribution to journalArticlepeer-review


The International Breast Cancer Study Group (IBCSG) has been conducting large, phase III clinical trials since 1978. Prior to 1986, these activities were carried out under the name of Ludwig Breast Cancer Study Group. Seven trials of adjuvant therapies are currently open for patient accrual, five of which are described in this report. The IBCSG has been a leader in the field of tailored treatment approaches for specific subpopulations of patients with breast cancer, believing that what is best for the majority may not be best for a defined minority.

Original languageEnglish
Pages (from-to)252-254
Number of pages3
JournalBreast Cancer Research
Issue number6
Publication statusPublished - Dec 2005

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Clinical trial update: International Breast Cancer Study Group'. Together they form a unique fingerprint.

Cite this